PWJ-46997-62015

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
1759791 (opens in a new window)	high	11 / 11	—	2 of 3 VAERS symptoms	same dose (2)	NC matches	2021-09-16 / 2021-09-16 / 2021-10-04 received the same day as the last call	case 1051342

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-08
Dose 1 — Pfizer-BioNTech
2021-09-16
Dose 2 — Pfizer-BioNTech
2021-10-01
Registered in v-safe
2021-10-01
Survey response — day 14, dose 2
MedDRA: Herpes gestationis, Office visit, Postpartum state — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: I was diagnosed with(b)(6) by my dermatologist. I experienced the first symptoms 13 days after my first vaccine dose, and 3 weeks postpartum. PG is rare and usually occurs in 2nd or 3rd trimester. Vaccine related?

MedDRA releases: 2024-11 · check-in free text available
2021-10-01
Report sent to call center — day 14, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-10-04
Call successful
Completed over the phone
2021-10-09
Survey response — day 21, dose 2
MedDRA: Blister, Rash — Feeling: Fair

Free text: Rash on the hands new blisters on right arm

MedDRA releases: 2024-11 · check-in free text available
2021-10-14
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-10-21
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-12-18
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-03-17
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-09-19
Survey response — 12 months, dose 2
MedDRA: Biopsy skin abnormal, Condition aggravated, Office visit, Pre-existing disease — Feeling: Fair

Free text: Reoccurring Pemphigoid gestationis with menstrual cycles. Identified via biopsy at dermatologist.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-08	Pfizer-BioNTech	No
2	2021-09-16	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 9 — day 14, dose 2

2021-10-01

Symptoms: I was diagnosed with(b)(6) by my dermatologist. I experienced the first symptoms 13 days after my first vaccine dose, and 3 weeks postpartum. PG is rare and usually occurs in 2nd or 3rd trimester. Vaccine related?

redacted (b)(6)

Release 10 — day 21, dose 2

2021-10-09

Symptoms: Rash on the hands new blisters on right arm

Release 12 — 12 months, dose 2

2022-09-19

Symptoms: Reoccurring Pemphigoid gestationis with menstrual cycles. Identified via biopsy at dermatologist.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Biopsy skin abnormal	·	·	✓
SD	Blister	·	·	✓
SD	Condition aggravated	·	·	✓
SD	Herpes gestationis	·	·	✓
SD	Office visit	·	·	✓
SD	Postpartum state	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Rash	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Possible VAERS report